Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.

Market Analysis and Insights: Global Ertapenem Sodium Market
The global Ertapenem Sodium market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Ertapenem Sodium Scope and Market Size
The global Ertapenem Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ertapenem Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity≥99%

Segment by Application
Ertapenem Sodium Injection
Other

The Ertapenem Sodium market is analysed and market size information is provided by regions (countries). Segment by Application, the Ertapenem Sodium market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Tecoland
Qilu Pharmaceutical
Beijing Lunarsun Pharmaceutical
Savior Lifetec Corporation
Zhejiang New Donghai Pharmaceutical
Iffect Chemphar
Sun Pharma